Dexilant
Product Images NDC 54868-6152

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexilant (NDC 54868-6152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (1dcfa9cd B78d 496c B61f Bbd6445ca0db 01)

Chemical structure of Dexlansoprazole, the active ingredient in Dexilant, showing its molecular arrangement including a benzimidazole ring, sulfoxide group, and trifluoroethoxy substituent.*

FDA Label Image

Figure (1dcfa9cd B78d 496c B61f Bbd6445ca0db 02)

A line graph depicting the plasma concentration (ng/mL) of Dexilant over time (hours) for two dosages: 30 mg and 60 mg. The graph shows concentration trends for both doses, with the 60 mg dose reaching higher peak plasma levels compared to the 30 mg dose, and both declining over a 24-hour period.*

FDA Label Image

Principal Display Panel (60 mg Capsule Bottle Label)

Packaging label for Dexilant 60 mg, distributed by Physicians Total Care, Inc. The label includes the lot number and expiration date, as well as a barcode and the NDC number 54868-6152-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.